Iris Löw-Friedrich
Vermögen: 215 653 $ am 31.05.2026
Vermögen: 215 653 $ am 31.05.2026
Dr. Iris Lw-Friedrich ist stellvertretende Aufsichtsratsvorsitzende bei Evotec SE, Chief Medical Officer & Executive Vice President bei UCB SA und Professorin an der Johann Wolfgang Goethe-Universität Frankfurt am Main. Sie ist Mitglied des Verwaltungsrats der Fresenius SE & Co. KGaA und Evotec SE. Dr. Lw-Friedrich war zuvor als Chairman bei Transcelerate Biopharma, Inc. beschäftigt, als Mitglied des Aufsichtsrats bei Heidelberg Pharma AG, als Director-Research & Development bei UCB Pharma GmbH, als Vice President-Global Projects bei BASF Pharma, als Vice President-Global Projects bei BASF AG, als Vice President-Clinical Development bei Hoechst AG, als Head-Global Clinical Management & VP bei Aventis Pharma AG und als Vice President-Clinical Development bei Hoechst Marion Roussel, Inc. Sie promovierte an der Johann Wolfgang Goethe-Universitt Frankfurt am Main.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVOTEC SE 0.02% | 31.12.2025 | 35’000 ( 0.02% ) | 215 653 $ | 31.05.2026 |
| 30.01.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| FRESENIUS SE & CO. KGAA | Direktor/Vorstandsmitglied | 13.05.2016 |
| SWEDISH ORPHAN BIOVITRUM AB | Direktor/Vorstandsmitglied | 08.05.2025 |
| SATELLOS BIOSCIENCE INC. | Direktor/Vorstandsmitglied | 18.06.2025 |
| FINANCIÈRE DE TUBIZE S.A. | Direktor/Vorstandsmitglied | 24.09.2025 |
| BIONTECH SE | Direktor/Vorstandsmitglied | 15.05.2026 |
Celosia Therapeutics Pty Ltd.
Celosia Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which uses gene therapy to treat neurodegenerative diseases | Vorsitzender | - |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Direktor/Vorstandsmitglied | 01.04.2019 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2000 |
| Unternehmen | Position | Ende |
|---|---|---|
| EVOTEC SE | Vorsitzender | 11.06.2026 |
| ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 20 |
|---|---|
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
BASF SE
BASF SE Chemicals: SpecialtyProcess Industries Manufactures plastic materials, precursors, chemicals for batteries, automotive OEM coatings, petrochemicals, intermediates, agrochemicals, industrial, nutrition & care additives | Process Industries |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
UCB SA
UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Evotec SE
Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Heidelberg Pharma AG
Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Financière de Tubize SA
Financière de Tubize SA Financial ConglomeratesFinance Operates as an investment holding company which invests in the chemical, pharmaceutical and film sectors | Finance |
Johann Wolfgang Goethe-Universität Frankfurt am Main
Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aventis Pharma AG | |
Hoechst Marion Roussel, Inc.
Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
BioNTech SE
BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
BASF Pharma | |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Satellos Bioscience, Inc.
Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
Frankfurt University Medical School
Frankfurt University Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celosia Therapeutics Pty Ltd.
Celosia Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which uses gene therapy to treat neurodegenerative diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen